Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts
  • Log out

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
  • Log out
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticlePractice

Guidelines for maternal codeine use during breastfeeding

Parvaz Madadi, Myla Moretti, Nada Djokanovic, Pina Bozzo, Irena Nulman, Shinya Ito and Gideon Koren
Canadian Family Physician November 2009, 55 (11) 1077-1078;
Parvaz Madadi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myla Moretti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nada Djokanovic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pina Bozzo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irena Nulman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinya Ito
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gideon Koren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

ABSTRACT

QUESTION In light of the recent evidence of adverse events in infants whose mothers use codeine medication, we have been struggling with the issue of how to manage codeine analgesia in our postpartum patients. What are some guidelines for the safe use of codeine during breastfeeding?

ANSWER Motherisk has summarized recent scientific evidence into suggested guidelines for the safe use of codeine during breastfeeding.

It is widely recognized that maternal pain should be managed following delivery, but the issue of how to adequately provide this pain relief has not been resolved. Any medication prescribed during the postpartum period must be safe and effective for mothers without causing harm to breastfed infants. Although there is an absence of scientific data supporting its use,1 many institutions in North America prescribe the combination of acetaminophen (300 mg), codeine (30 mg), and caffeine (15 mg) (ie, Tylenol No. 3) for analgesia following cesarean section or episiotomy.2 The rationale for choosing codeine analgesia appears to be institutional tradition and years of experience in the hospital setting. However, mothers rarely have follow-up appointments once discharged from the hospital, and recent evidence of adverse drug reactions in breastfed infants whose mothers are prescribed outpatient codeine medication3–5 necessitates guidelines in this population (Boxes 1 and 2).

Postpartum use

A review of the pharmacologic mechanism of codeine analgesia sheds light on issues surrounding its postpartum use.6 Codeine is a prodrug that must be metabolized via the cytochrome P450 2D6 (CYP 2D6) enzyme into morphine to elicit an analgesic effect7,8; however, the CYP 2D6 gene is highly polymorphic.9 While codeine is effective for most individuals worldwide who possess 2 functional copies of the gene, about 8% of Europeans do not possess any active gene copies, and thus are unable to receive analgesia.10 On the other hand, functional duplications of the CYP 2D6 gene (which range from 2% to 40% of individuals, depending on ethnic background10) enhance morphine biotransformation from codeine11 and have been associated with adverse events,12,13 including death in a breastfed infant.4,5 There are commercial tests available for CYP 2D6 genetic screening; however, clinical trials supporting its introduction in the hospital setting have not yet been performed.

Box 1.

Codeine use during breastfeeding

A large number of women are treated for pain following cesarean section or episiotomy.
  • It is important to effectively treat postpartum pain.

  • Codeine is widely used for postpartum pain, mostly in combination with acetaminophen. Tylenol No. 3 is the most common codeine-acetaminophen combination in clinical use.

  • Recent research from Motherisk suggests that codeine might not be safe for all breastfed infants, as in a minority of cases it might cause CNS depression and apnea.

  • A minority of mothers might convert more codeine to morphine in their bodies, putting their babies at risk of side effects or even death.

  • Infants appear to be more sensitive to the effects of narcotic opioids, such as morphine, than older children or adults.

  • CNS—central nervous system.

  • While maternal genotype should certainly be considered before codeine is prescribed, patient education might be an equally important preventive measure. Newborn infants appear to be most sensitive to the effects of narcotic opioids as compared with older infants5,14–16; however, many mothers are unaware of the symptoms of central nervous system (CNS) depression and what to look for in their babies. In any case in which a baby is not fed well, does not wake up to be fed, does not gain weight, or shows limpness, he or she should be examined by a physician. These symptoms tend to appear after 4 days3,5 of continuous breastfeeding while using codeine and are likely due to the accumulation of morphine in the infant.17 It follows that higher maternal codeine dose is associated with a higher risk of neonatal adverse events.3,5 Thus, if pain still necessitates codeine after 4 days, an attempt should be made to decrease the dose or to switch to non-codeine painkillers (eg, non-steroidal anti-inflammatory drugs).5 There is also a strong correlation between CNS depression in the mother and the breastfed baby,5 which can serve as a warning flag for mothers; if a mother herself feels groggy or sedated, her baby should be examined by a physician for signs of CNS depression as well.

    Box 2.

    Motherisk guidelines for safe use of medications that contain codeine during breastfeeding: These guidelines are based on the available scientific data

    In most cases, the occurrence of CNS depression is consistent between the mother and the baby. If the mother suffers from symptoms of CNS depression (eg, somnolence, grogginess), a physician should examine the baby for signs of CNS depression as well.
    • If the baby is not fed well does not wake up to be fed does not gain weight or shows limpness he or she should be examined by a physician.

    • Central nervous system depression in the baby appears to worsen after 4 days probably owing to the accumulation of morphine with more breastfeeding. If possible codeine should not be used for longer than 4 days. If pain still necessitates codeine an attempt should be made to decrease the dose or to switch to non-codeine painkillers (eg NSAIDs).

    • Women who convert more codeine to morphine have a duplication of the gene encoding for cytochrome P450 2D6. This genetic predisposition can be detected by genetic test. This test although not available in most hospitals is available on the market.

    • Although codeine is widely used in North America 9 randomized studies comparing the use of codeine with various NSAIDs in laparotomy cases (ie abdominal surgery) failed to show codeine to be superior in pain relief.

  • CNS—central nervous system, NSAIDs—nonsteroidal anti-inflammatory drugs.

  • Conclusion

    As the postpartum length of hospital stay has decreased in Canada,18 the onus for providing a safe and effective analgesic for maternal outpatient use has increased. The strategy of replacing codeine with another opioid analgesic is troublesome in the absence of safety data and clinical experience. However, if codeine is to remain the first-line treatment of postpartum pain, practitioners, as well as patients, should be educated on its risks.

    MOTHERISK

    Motherisk questions are prepared by the Motherisk Team at the Hospital for Sick Children in Toronto, Ont. Dr Madadi, Ms Moretti, Ms Bozzo, and Drs Djokanovic and Ito are members of the Motherisk Program. Dr Nulman is Associate Director and Dr Koren is Director of the Motherisk Program. Dr Koren is supported by the Research Leadership for Better Pharmacotherapy during Pregnancy and Lactation. He holds the Ivey Chair in Molecular Toxicology in the Department of Medicine at the University of Western Ontario in London.

    Do you have questions about the effects of drugs, chemicals, radiation, or infections in women who are pregnant or breastfeeding? We invite you to submit them to the Motherisk Program by fax at 416 813-7562; they will be addressed in future Motherisk Updates.

    Published Motherisk Updates are available on the Canadian Family Physician website (www.cfp.ca) and also on the Motherisk website (www.motherisk.org).

    Footnotes

    • Competing interests

      None declared

    • Copyright© the College of Family Physicians of Canada

    References

    1. ↵
      NautaMLandsmeerMLKorenGEffectiveness and safety of NSAIDs versus acetaminophen/codeine in the treatment of maternal post partum pain: a systematic reviewAm J Surg200919825661
      OpenUrlCrossRefPubMed
    2. ↵
      PeterEAJanssenPAGrangeCSDouglasMJIbuprofen versus acetaminophen with codeine for the relief of perineal pain after childbirth: a randomized controlled trialCMAJ2001165912039
      OpenUrlAbstract/FREE Full Text
    3. ↵
      MadadiPShiraziFWalterFGKorenGEstablishing causality of CNS depression in breastfed infants following maternal codeine usePaediatr Drugs2008106399404
      OpenUrlCrossRefPubMed
    4. ↵
      KorenGCairnsJChitayatDGaedigkALeederSJPharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed motherLancet20063689536704
      OpenUrlCrossRefPubMed
    5. ↵
      1. Madadi P,
      2. Ross CJ,
      3. Hayden MR,
      4. Carleton BC,
      5. Gaedigk A,
      6. Leeder JS,
      7. et al.
      Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control studyClin Pharmacol Ther2009851315. Epub 2008 Aug 20.
      OpenUrlCrossRefPubMed
    6. ↵
      MadadiPKorenGPharmacogenetic insights into codeine analgesia: implications to pediatric codeine usePharmacogenomics200899126784
      OpenUrlCrossRefPubMed
    7. ↵
      ChenZRSomogyiAAReynoldsGBochnerFDisposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisersBr J Clin Pharmacol199131438190
      OpenUrlCrossRefPubMed
    8. ↵
      YueQYHasselstromJSvenssonJOSaweJPharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquineBr J Clin Pharmacol199131663542
      OpenUrlCrossRefPubMed
    9. ↵
      Human Cytochrome P450 (CYP) Allele Nomenclature Committee [website]. CYP2D6 allele nomenclature. Human Cytochrome P450 (CYP) Allele Nomenclature Committee; 2009. Available from: www.cypalleles.ki.se/cyp2d6.htm. Accessed 2009 Feb 5.
    10. ↵
      SistonenJSajantilaALaoOCoranderJBarbujaniGFuselliSCYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structurePharmacogenet Genomics200717293101
      OpenUrlPubMed
    11. ↵
      1. Kirchheiner J,
      2. Schmidt H,
      3. Tzvetkov M,
      4. Keulen JT,
      5. Lötsch J,
      6. Roots I,
      7. et al.
      Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplicationPharmacogenomics J20077425765. Epub 2006 Jul 4.
      OpenUrlCrossRefPubMed
    12. ↵
      1. Gasche Y,
      2. Daali Y,
      3. Fathi M,
      4. Chiappe A,
      5. Cottini S,
      6. Dayer P,
      7. et al.
      Codeine intoxication associated with ultrarapid CYP2D6 metabolismN Engl J Med200435127282731. Erratum in: N Engl J Med 2005;352(6)638.
      OpenUrlCrossRefPubMed
    13. ↵
      DalénPFrengellCDahlMLSjöqvistFQuick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquineTher Drug Monit19971955434
      OpenUrlCrossRefPubMed
    14. ↵
      WayWLCostleyECLeongwayERespiratory sensitivity of the newborn infant to meperidine and morphineClin Pharmacol Ther1965645461
      OpenUrlPubMed
    15. KorenGButtWChinyangaHSoldinSTanYKPapeKPostoperative morphine infusion in newborn infants: assessment of disposition characteristics and safetyJ Pediatr198510769637
      OpenUrlCrossRefPubMed
    16. ↵
      1. Bouwmeester NJ,
      2. Hop WC,
      3. van Dijk M,
      4. Anand KJ,
      5. van den Anker JN,
      6. Tibboel D
      Postoperative pain in the neonate: age-related differences in morphine requirements and metabolismIntensive Care Med20032911200915. Epub 2003 Jul 25.
      OpenUrlCrossRefPubMed
    17. ↵
      1. Willmann S,
      2. Edginton AN,
      3. Coboeken K,
      4. Ahr G,
      5. Lippert J
      Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling studyClin Pharmacol Ther2009Epub ahead of print.
    18. ↵
      CargillYMartelMJSociety of Obstetricians and Gynaecologists of CanadaPostpartum maternal and newborn dischargeJ Obstet Gynaecol Can200729435763
      OpenUrlPubMed
    PreviousNext
    Back to top

    In this issue

    Canadian Family Physician: 55 (11)
    Canadian Family Physician
    Vol. 55, Issue 11
    1 Nov 2009
    • Table of Contents
    • About the Cover
    • Index by author
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Guidelines for maternal codeine use during breastfeeding
    (Your Name) has sent you a message from The College of Family Physicians of Canada
    (Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Guidelines for maternal codeine use during breastfeeding
    Parvaz Madadi, Myla Moretti, Nada Djokanovic, Pina Bozzo, Irena Nulman, Shinya Ito, Gideon Koren
    Canadian Family Physician Nov 2009, 55 (11) 1077-1078;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Respond to this article
    Share
    Guidelines for maternal codeine use during breastfeeding
    Parvaz Madadi, Myla Moretti, Nada Djokanovic, Pina Bozzo, Irena Nulman, Shinya Ito, Gideon Koren
    Canadian Family Physician Nov 2009, 55 (11) 1077-1078;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • ABSTRACT
      • Postpartum use
      • Conclusion
      • Footnotes
      • References
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    • No related articles found.
    • PubMed
    • Google Scholar

    Cited By...

    • Sedating drugs and breastfeeding
    • Oxycodone administered as postpartum pain relief is associated with maternal report of infant central nervous system depression in breastfed infants
    • Pregnancy, breast-feeding and drugs used in dentistry
    • Has the time come to phase out codeine?
    • Google Scholar

    More in this TOC Section

    Practice

    • Is 45 the new 50 in colorectal cancer screening?
    • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
    • Determining if and how older patients can safely stay at home with additional services
    Show more Practice

    Motherisk Update

    • Hepatitis A infection during pregnancy
    • Fluconazole use during breastfeeding
    • Is it safe to breastfeed while taking methylphenidate?
    Show more Motherisk Update

    Similar Articles

    Navigate

    • Home
    • Current Issue
    • Archive
    • Collections - English
    • Collections - Française

    For Authors

    • Authors and Reviewers
    • Submit a Manuscript
    • Permissions
    • Terms of Use

    General Information

    • About CFP
    • About the CFPC
    • Advertisers
    • Careers & Locums
    • Editorial Advisory Board
    • Subscribers

    Journal Services

    • Email Alerts
    • Twitter
    • RSS Feeds

    Copyright © 2023 by The College of Family Physicians of Canada

    Powered by HighWire